International Stem Cell Corporation (ISCO)
OTCMKTS · Delayed Price · Currency is USD
0.1700
0.00 (0.00%)
Jun 15, 2026, 9:30 AM EST
International Stem Cell Revenue
International Stem Cell had revenue of $2.32M in the quarter ending March 31, 2026, with 8.74% growth. This brings the company's revenue in the last twelve months to $9.29M, up 2.21% year-over-year. In the year 2025, International Stem Cell had annual revenue of $9.10M with 0.17% growth.
Revenue (ttm)
9.29M
Revenue Growth
+2.21%
P/S Ratio
0.15
Revenue / Employee
281.39K
Employees
33
Market Cap
1.36M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.10M | 15.00K | 0.17% |
| Dec 31, 2024 | 9.09M | 1.30M | 16.64% |
| Dec 31, 2023 | 7.79M | -391.00K | -4.78% |
| Dec 31, 2022 | 8.18M | 1.00M | 13.99% |
| Dec 31, 2021 | 7.18M | 48.00K | 0.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Evofem Biosciences | 20.24M |
| Clearside Biomedical | 3.33M |
| Avenue Therapeutics | 1.40M |
| Lyra Therapeutics | 398.00K |
| AXIM Biotechnologies | 92.90K |
International Stem Cell News
- 1 year ago - International Stem Cell reports FY24 EPS (3c) vs. (2c) last year - TheFly
- 1 year ago - International Stem Cell Corporation Announces 2024 Fourth Quarter and Year-End Results - Accesswire
- 2 years ago - Eighteenth edition of Fujio Cup Quiz won by Kasturba Medical College, India in the NCRM NICHE 2023 international stem cell meeting. - Business Wire
- 4 years ago - International Stem Cell Corporation Announces Strong Financial Results for the Quarter Ended March 31, 2022 - Accesswire